Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivipansel for Vaso-Occlusive Crisis in Sickle Cell Disease
NCT02187003Phase 3Completed
- Sponsor
- Biossil
- Start
- Jun 2015
- Primary completion
- May 2019
- Modality
- Bivalent/Multivalent Binders, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of rivipansel in sickle cell disease (SCD), sponsored by Biossil. Started Jun 2015; status: completed.
02
Drugs
rivipansel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02187003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187003.